During the past decade, Namik Kemal Universitesi Tip Fakultesi conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Namik Kemal Universitesi Tip Fakultesi" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Namik Kemal Universitesi Tip Fakultesi" are "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials), "Renal Cell Carcinoma (RCC)" (1 trials), "Secondary Prevention" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Namik Kemal Universitesi Tip Fakultesi" in a lesser frequency.

Most popular intervention types in "Namik Kemal Universitesi Tip Fakultesi" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "Carboplatin" (2 trials), "Olaparib" (2 trials), "ASA 100 mg" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Namik Kemal Universitesi Tip Fakultesi" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Namik Kemal Universitesi Tip Fakultesi". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Namik Kemal Universitesi Tip Fakultesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Namik Kemal Universitesi Tip Fakultesi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".